WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

The Food and Drug Administration has approved a new, first-of-its-kind semiannual HIV prevention medication, Gilead Sciences ...

And more pharma news updates from Pharmalittle.

The United States has given its approval to the world’s first twice-a-year injection for HIV prevention, marking a ...

The drug, known as Yeztugo, is the first and only twice-yearly option available in the U.S. for people who need or want PrEP, Gilead said Wednesday. Just under 100% of patients who received the drug ...

Gilead Sciences shows strong Q1 execution, pipeline momentum, and margin upside, led by HIV and PrEP launches. See why GILD ...

Analysts at Citi said that while the clinical hold impacts the targeted commercial launch of the GS-1720/GS-4182 regimen, previously expected around 2029/2030, they believe the setback is minor, as it ...

Hulu’s television adaptation of Margaret Atwood’s landmark 1985 feminist novel, The Handmaid’s Tale, has now come to an end.

Regional track and field meets will be held around the state starting Wednesday and running through Saturday. Here's where the locals will compete.

Gilead Sciences brings to the collaboration a wealth of global ... The contents of this press release was provided from an external third party provider. This website is not responsible for, and does ...